What are the CDC guidelines on antiretroviral therapy (ART) regimens for the treatment of HIV infection?

Updated: Jan 15, 2019
  • Author: Jason F Okulicz, MD, FACP, FIDSA; more...
  • Print
Answer

Answer

Recommended ART regimens for treatment-naive patients with HIV infection are as follows (*lamivudine may be substituted for emtricitabine or vice versa, if a non–fixed-dose NRTI combination is desired):

All regimens are INSTI-based, as follows:

  • Bictegravir/tenofovir alafenamide/emtricitabine
  • Dolutegravir/abacavir/lamivudine* (only for patients who are HLA-B*5701 negative)
  • Dolutegravir plus either tenofovir disoproxil fumarate/emtricitabine* or tenofovir alafenamide/emtricitabine
  • Raltegravir plus either tenofovir disoproxil fumarate/emtricitabine* or tenofovir alafenamide/emtricitabine

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!